Eike Nagel

Eike Nagel serves as DZHK Professor for Cardiology and Director of the DZHK Centre for Cardiovascular Imaging at Goethe University Hospital Frankfurt. He leads the Institute for Experimental and Translational Cardiovascular Imaging (Goethe CVI) within the Medical Faculty and holds dual appointments as Consultant Cardiologist in Cardiology and Radiology departments. A founding member and Past President of the Society for Cardiovascular Magnetic Resonance (SCMR), his career spans over 25 years of pioneering CMR research with 500+ publications.

Research Focus: Prof. Nagel specializes in translational cardiovascular imaging biomarkers for coronary artery disease, cardiomyopathy, and heart failure (HF-REF/HFpEF). His work develops and validates clinical CMR techniques including stress perfusion MRI (adenosine/regadenoson), dobutamine stress MRI, and quantitative tissue mapping (T1/T2/ECV) to characterize myocardial pathology and improve diagnostic pathways. Current investigations target myocardial fingerprinting for HFpEF classification and biomarker qualification.

Publication Impact: His recent research demonstrates leadership in standardizing CMR protocols and validating tissue characterization biomarkers. Key trends include myocardial tissue quantification for coronary disease prognosis, mapping techniques for early sarcoidosis detection, and multi-center consensus on imaging endpoints – all driving clinical implementation of quantitative CMR.

Scientific Recognition:

• Gold Medal of the Society for Cardiovascular Magnetic Resonance (SCMR) (2016)

Training & Research Leadership: Prof. Nagel directs Goethe CVI's Clinical Trial Unit supporting non-commercial studies (e.g., MR-INFORM, Decipher-HFpEF) as imaging core lab. He mentors through international CMR fellowships for clinicians, physicists, and radiographers, emphasizing standardized acquisition and interpretation protocols.

Institutional Role: The Goethe CVI Institute under his leadership integrates experimental research with clinical service, focusing on imaging standardization to personalize cardiovascular treatment. Current initiatives include IMPReSSION Study for myocardial inflammation and Distr@l platform for distributed CMR analysis.